Literature DB >> 15313535

Evaluation of the contemporary occurrence rates of metallo-beta-lactamases in multidrug-resistant Gram-negative bacilli in Japan: report from the SENTRY Antimicrobial Surveillance Program (1998-2002).

Ronald N Jones1, Lalitagauri M Deshpande, Jan M Bell, John D Turnidge, Shigeru Kohno, Yoichi Hirakata, Yasuo Ono, Yukihisa Miyazawa, Sayoko Kawakama, Matsuhisa Inoue, Yasuyoshi Hirata, Mark A Toleman.   

Abstract

Metallo-beta-lactamases (M beta L) were initially characterized in Japan, usually of the IMP-type, and found in Pseudomonas aeruginosa (PSA), Acinetobacter spp. (ACB), or Serratia marcescens (SM). The number of M beta L types has increased worldwide, but geographic dissemination within Japan has appeared limited. This study compares baseline levels of M beta L resistance from two 22-center studies (1996-1997) to the longitudinal sample (3 sites) of Japanese isolates from the SENTRY Antimicrobial Surveillance Program (1998-2002). All minimal inhibitory concentration results were determined by reference methods. A total of 26.8% PSA, 3.4% ACB, and 3.1% Enterobacteriaceae (enterobacters and SM) with resistance to monitored carbapenems (CARB) (minimal inhibitory concentration, > or =8 microg/mL) were screened for M beta L production by disk approximation tests (EDTA and 2-MPA inhibitors), CARB hydrolysis by enzyme extracts, and selected PCR primers for known M beta L types. All M beta L-positive strains (10) were sequenced to determine enzyme identification. Clonality in each center was determined by automated ribotyping and PFGE. The CARB susceptibility rates in PSA decreased (80.7% to 62.0%) over the monitored interval (1998-2002), but varied by medical center location. Among CARB-resistant isolates, 10.8% were attributed to M beta L strains (1.1% of all PSA tested). M beta L identification showed the following: five PSA (three IMP-1, two IMP-2), four SM (one IMP-1, two IMP-1 + OXA-1, and one IMP-11). Also a single ACB had an IMP-1. Eight of 10 M beta L isolations occurred between 2000 and 2002; four occurred in 2002. BRL42715, an AMP-C inhibitor, confirmed AMP-C-mediated resistance in 87.3% of PSA, and outer membrane protein changes were also discovered by membrane studies. Prior results (22 sites, 1997-1998) showed CARB resistance at 22.4-25.6% and 0.5-0.9% M beta Ls (IMP-1) overall; it was slightly elevated in this SENTRY Program sample. In conclusion, M beta L-producing strains from several species persist in Japan, but represent a distinct minority of all CARB-resistant strains (1998-2002). Although M beta L rates appear generally stable in Japan, continued surveillance for these mechanisms seems to be a prudent practice, because of the mobility of the genetic determinants and the emergence of novel enzyme types, especially among the Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313535     DOI: 10.1016/j.diagmicrobio.2004.04.007

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  In vitro and in vivo activities of a new cephalosporin, FR264205, against Pseudomonas aeruginosa.

Authors:  Shinobu Takeda; Toru Nakai; Yoshimi Wakai; Fumiaki Ikeda; Kazuo Hatano
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

2.  Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.

Authors:  Zishuo Cheng; Christopher R Bethel; Pei W Thomas; Ben A Shurina; John-Paul Alao; Caitlyn A Thomas; Kundi Yang; Steven H Marshall; Huan Zhang; Aidan M Sturgill; Andrea N Kravats; Richard C Page; Walter Fast; Robert A Bonomo; Michael W Crowder
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Efficacy of calcium-EDTA as an inhibitor for metallo-β-lactamase in a mouse model of Pseudomonas aeruginosa pneumonia.

Authors:  Nobumasa Aoki; Yoshikazu Ishii; Kazuhiro Tateda; Tomoo Saga; Soichiro Kimura; Yoshiaki Kikuchi; Tetsuo Kobayashi; Yoshinari Tanabe; Hiroki Tsukada; Fumitake Gejyo; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

4.  Metallo-beta-lactamase-producing Pseudomonas spp. in Korea: high prevalence of isolates with VIM-2 type and emergence of isolates with IMP-1 type.

Authors:  Kyungwon Lee; Ae Ja Park; Moon Yeun Kim; Hee Joo Lee; Ji-Hyun Cho; Jung Oak Kang; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2009-06-23       Impact factor: 2.759

5.  Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.

Authors:  Alecander E LaCuran; Kevin M Pegg; Eleanor M Liu; Christopher R Bethel; Ni Ai; William J Welsh; Robert A Bonomo; Peter Oelschlaeger
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

6.  Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates.

Authors:  Renata C Picão; Soraya S Andrade; Adriana Gianinni Nicoletti; Eloiza H Campana; Gabriela C Moraes; Rodrigo E Mendes; Ana C Gales
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.